Table 1 shows as reference (left columns for refs 7 and 8) all the myostatin-related miRs, previously reported for MDSC as downregulated in vivo over 2-fold (<0.5 as compared to controls) by the T2D/O milieu, and also downregulated in most cases in the female ZF4-SC to <0.5 by dyslipidemic OZ serum, but not by normal LZ serum. The gene discussed is MSTN; the disease is type 2 diabetes mellitus.